| Title |
Proposal of remission criteria for IgA nephropathy
|
|---|---|
| Published in |
Clinical and Experimental Nephrology, August 2013
|
| DOI | 10.1007/s10157-013-0849-x |
| Pubmed ID | |
| Authors |
Yusuke Suzuki, Keiichi Matsuzaki, Hitoshi Suzuki, Naoko Sakamoto, Kensuke Joh, Tetsuya Kawamura, Yasuhiko Tomino, Seiichi Matsuo |
| Abstract |
The remission criteria of immunoglobulin A (IgA) nephropathy have varied depending on the clinical study. Therefore, nephrologists cannot make a uniform assessment of treatment outcomes and the standardization of explanations of the condition is difficult in patients with IgA nephropathy. This study aims to propose clinical remission criteria for IgA nephropathy based on a nationwide opinion survey in Japan regarding IgA nephropathy remission/relapse. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 30 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 8 | 27% |
| Student > Ph. D. Student | 6 | 20% |
| Other | 4 | 13% |
| Student > Master | 3 | 10% |
| Professor > Associate Professor | 2 | 7% |
| Other | 3 | 10% |
| Unknown | 4 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 53% |
| Psychology | 2 | 7% |
| Environmental Science | 1 | 3% |
| Economics, Econometrics and Finance | 1 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
| Other | 2 | 7% |
| Unknown | 7 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 August 2013.
All research outputs
#15,526,761
of 23,849,058 outputs
Outputs from Clinical and Experimental Nephrology
#389
of 769 outputs
Outputs of similar age
#120,480
of 200,548 outputs
Outputs of similar age from Clinical and Experimental Nephrology
#3
of 5 outputs
Altmetric has tracked 23,849,058 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 769 research outputs from this source. They receive a mean Attention Score of 3.7. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 200,548 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.